Skip to content

Understanding the Pharmacology: What is xanthohumol?

4 min read

Xanthohumol is a prenylated flavonoid found almost exclusively in the female flowers of the hops plant (Humulus lupulus), a primary ingredient in beer brewing. In vitro studies and animal research have highlighted its diverse pharmacological properties, including significant antioxidant and anti-inflammatory effects.

Quick Summary

A prenylated flavonoid in hops, xanthohumol is researched for its antioxidant, anti-inflammatory, and potential anti-cancer effects. Found in small amounts in beer and higher concentrations in supplements, its therapeutic applications are limited by low bioavailability. Research explores mechanisms against metabolic and neurodegenerative diseases.

Key Points

  • Source: Xanthohumol is a prenylated flavonoid found predominantly in hops, the female flowers of the Humulus lupulus plant.

  • Brewing vs. Supplementation: The concentration of xanthohumol is very low in beer due to its conversion during the brewing process, so supplements are needed for a pharmacologically significant dose.

  • Antioxidant and Anti-inflammatory: It exhibits powerful antioxidant effects by scavenging free radicals and has potent anti-inflammatory properties by inhibiting pathways like NF-κB.

  • Metabolic Benefits: In animal studies, xanthohumol has shown promise in improving metabolic parameters like cholesterol, blood sugar, and fat accumulation.

  • Potential Anti-cancer Activity: Preclinical research suggests potential chemopreventive effects by inhibiting cancer cell proliferation, invasion, and angiogenesis.

  • Low Bioavailability: A major limitation is its poor oral bioavailability in humans, as it is quickly metabolized and excreted, though research is exploring improved delivery methods.

  • Metabolites: The effects of xanthohumol may also be mediated by its metabolites, such as the phytoestrogen 8-prenylnaringenin, formed during digestion.

In This Article

What is Xanthohumol?

Xanthohumol (XN) is a type of flavonoid, a class of plant-derived compounds known for their health benefits. Specifically, it is a prenylated chalcone, identified in 1957, that is highly concentrated in the cones of the female hop plant (Humulus lupulus). While hops are most famous for their use in brewing, xanthohumol itself is largely isomerized into isoxanthohumol (IXN) and other related compounds during the brewing process due to high heat. Therefore, the amount of xanthohumol in a typical beer is very low and insufficient to produce the pharmacological effects observed in research studies.

Sources and Bioavailability

Where is Xanthohumol Found?

As the chief prenylated chalcone in hops, xanthohumol is found in extracts derived from the plant. For those seeking to obtain a pharmacologically relevant dose, supplements and fortified food products are the main route, as regular consumption of beer provides only trace amounts. Supplement manufacturers offer hop extracts containing concentrated xanthohumol, often standardized to a specific percentage.

The Challenge of Low Bioavailability

One of the primary challenges for therapeutic application of xanthohumol is its poor oral bioavailability. Research indicates that when ingested orally, a significant portion of xanthohumol is poorly absorbed by the small intestine and is rapidly metabolized. It is extensively biotransformed by the gut microbiota and liver enzymes into various metabolites, including isoxanthohumol (IXN) and 8-prenylnaringenin (8-PN). The biological activity of these metabolites may differ from the parent compound, adding complexity to understanding its overall effects. To overcome this limitation, research is exploring innovative delivery systems and formulations, such as micellar solubilization, to enhance its absorption and effectiveness.

Pharmacological Mechanisms

The broad-ranging therapeutic effects of xanthohumol are attributed to its multi-targeted actions within the body, which include:

  • Potent Antioxidant Activity: Xanthohumol effectively scavenges reactive oxygen species (ROS), which helps prevent oxidative stress and subsequent cellular damage. It also activates the Nrf2 pathway, which regulates antioxidant protein expression.
  • Anti-inflammatory Modulation: It inhibits inflammatory pathways, such as the NF-κB pathway, which are often overactive in chronic diseases. This suppression reduces the expression of pro-inflammatory cytokines like IL-6.
  • Modulation of Cellular Metabolism: Xanthohumol influences key metabolic pathways, notably by activating AMPK (AMP-activated protein kinase). This activation can inhibit fat and glucose synthesis, improving glucose tolerance and insulin resistance. It also appears to interact with hormone receptors like the Farnesoid X Receptor (FXR) to help regulate blood fat and sugar levels.

Research Findings and Therapeutic Potential

Metabolic Syndrome and Cardiovascular Health

Animal studies show that xanthohumol can mitigate diet-induced obesity, reduce weight gain, and improve lipid profiles. Researchers at Oregon State University found that xanthohumol and its derivative, tetrahydroxanthohumol (TXN), helped reduce cholesterol and blood sugar levels in lab tests. The compound also exhibits antiplatelet and antithrombotic properties, which could reduce the risk of cardiovascular events without increasing bleeding risk.

Potential Anti-cancer and Other Effects

Laboratory studies have identified xanthohumol's chemopreventive and anti-cancer potential by inhibiting cell proliferation, inducing apoptosis (programmed cell death), and suppressing angiogenesis (new blood vessel formation) in various cancer cell lines. Areas of research include:

  • Breast cancer
  • Ovarian cancer
  • Prostate cancer
  • Pancreatic cancer
  • Colon cancer
  • Leukemia

Other Health Benefits

Additional research has investigated xanthohumol for other potential applications, including:

  • Neuroprotection: Studies suggest it may have a protective effect against age-related brain damage and neurodegenerative disorders like Alzheimer's disease.
  • Menopausal Symptoms: Certain metabolites of xanthohumol exhibit estrogenic activity, showing potential as an alternative therapy for menopausal symptoms.
  • Antimicrobial Activity: It has demonstrated potent activity against a range of microorganisms, including bacteria like Staphylococcus aureus and Clostridium difficile, as well as some viruses.

Xanthohumol vs. Other Flavonoids

Feature Xanthohumol (XN) Quercetin (Common Flavonoid) Resveratrol (Polyphenol in Grapes)
Source Hops (Humulus lupulus) Onions, apples, berries Grapes, red wine
Chemical Class Prenylated Chalcone Flavonol Stilbenoid (not a flavonoid)
Key Mechanism Antioxidant, anti-inflammatory (via NF-κB, Nrf2) Antioxidant, anti-inflammatory (various pathways) Antioxidant, anti-inflammatory, mimics caloric restriction
Bioavailability Low oral bioavailability; extensively metabolized Variable, generally low; better with specific formulations Variable, generally low; rapid metabolism
Unique Property Unique prenyl group, potent anti-cancer activity in vitro Found in a wide variety of common foods Activates sirtuins, a class of proteins associated with longevity

Considerations and Safety

Is Xanthohumol Safe?

Clinical trials have indicated that xanthohumol is safe and well-tolerated at daily doses of up to 24 mg per day for at least 8 weeks in healthy adults. Animal studies using much higher dosages have shown no significant toxicity, though mild liver effects were noted at extremely high doses in one rat study. Further human studies are needed to confirm the safety and efficacy of higher doses over longer periods.

Potential Drug Interactions

While the safety profile is generally favorable, xanthohumol does interact with metabolic enzymes, including cytochrome P450 enzymes. This raises the potential for drug interactions, especially for medications metabolized by these pathways. Anyone taking prescription medication should consult a healthcare provider before starting a xanthohumol supplement. Given its potential impact on hormone receptors and platelet function, caution should also be exercised by individuals with hormone-sensitive conditions or those on blood-thinning medication.

Conclusion

What is xanthohumol? It is a natural flavonoid from the hop plant that has shown promising pharmacological properties in preclinical studies, particularly for its antioxidant, anti-inflammatory, and anti-cancer effects. While the scientific evidence from in vitro and animal models is robust, significant challenges remain, primarily its low oral bioavailability and limited human data, especially concerning long-term effects and optimal dosing. Further research, including more human clinical trials, is necessary to fully realize xanthohumol's potential as a therapeutic or preventive agent for chronic diseases. In the meantime, it continues to be available as a dietary supplement and is a key area of study for natural product pharmacology. For authoritative scientific information on clinical studies, the ClinicalTrials.gov website is a valuable resource.

Frequently Asked Questions

Xanthohumol is a prenylated flavonoid extracted from the cones of the female hop plant (Humulus lupulus). Hops are best known as a key ingredient in beer brewing.

No, drinking typical beer does not provide a pharmacologically effective dose of xanthohumol. The brewing process causes most of the xanthohumol to isomerize into other compounds, and the final concentration in beer is very low.

Its main pharmacological effects include powerful antioxidant and anti-inflammatory activity. It can scavenge reactive oxygen species and inhibit key inflammatory pathways, which may help prevent chronic disease.

Yes, extensive research, primarily in laboratory and animal models, has explored its potential anti-cancer effects. Studies suggest it can inhibit the growth of various cancer cells by inducing apoptosis and blocking angiogenesis.

The biggest challenge is its poor oral bioavailability. After ingestion, it is not well absorbed and is rapidly metabolized by gut bacteria and the liver, limiting the amount that reaches systemic circulation.

Small-scale human clinical trials have found xanthohumol supplements to be safe and well-tolerated at specific doses (e.g., 24 mg/day for 8 weeks). However, more research is needed, especially on long-term safety and higher dosages.

Yes, its metabolite, 8-prenylnaringenin (8-PN), is a potent phytoestrogen with significant estrogenic activity. This has led to research on its potential use for menopausal symptoms.

Yes, it can interact with phase I and II metabolic enzymes in the liver, such as the cytochrome P450 enzymes. Individuals on prescription medications, particularly those metabolized by these enzymes, should consult a healthcare provider.

Beyond cancer and inflammation, research is exploring xanthohumol's potential in treating metabolic syndrome, cardiovascular disease, liver conditions, neurodegenerative disorders, and various microbial infections.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.